BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19808642)

  • 21. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of the glomerular microvasculature is regulated by VEGFR-3.
    Donnan MD; Deb DK; Onay T; Scott RP; Ni E; Zhou Y; Quaggin SE
    Am J Physiol Renal Physiol; 2023 Jan; 324(1):F91-F105. PubMed ID: 36395385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease.
    Lee HS; Hos D; Blanco T; Bock F; Reyes NJ; Mathew R; Cursiefen C; Dana R; Saban DR
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3140-8. PubMed ID: 26024097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF-C, VEGF-D and VEGFR-3 expression in peripheral neuroblastic tumours.
    Ramani P; Nash R; Radevsky L; Patel A; Luckett M; Rogers C
    Histopathology; 2012 Dec; 61(6):1006-16. PubMed ID: 22804730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.
    Blacker HA; Orgeig S
    J Comp Physiol B; 2012 Jan; 182(1):109-26. PubMed ID: 21800152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses.
    Zhou HJ; Chen X; Huang Q; Liu R; Zhang H; Wang Y; Jin Y; Liang X; Lu L; Xu Z; Min W
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):603-15. PubMed ID: 24407031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.
    Matsumoto M; Roufail S; Inder R; Caesar C; Karnezis T; Shayan R; Farnsworth RH; Sato T; Achen MG; Mann GB; Stacker SA
    Clin Exp Metastasis; 2013 Aug; 30(6):819-32. PubMed ID: 23591595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.
    Spinella F; Caprara V; Di Castro V; Rosanò L; Cianfrocca R; Natali PG; Bagnato A
    J Mol Med (Berl); 2013 Mar; 91(3):395-405. PubMed ID: 22965194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis.
    Kinashi H; Ito Y; Sun T; Katsuno T; Takei Y
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?
    Goyal S; Chauhan SK; El Annan J; Nallasamy N; Zhang Q; Dana R
    Arch Ophthalmol; 2010 Jul; 128(7):819-24. PubMed ID: 20625040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.
    Durré T; Morfoisse F; Erpicum C; Ebroin M; Blacher S; García-Caballero M; Deroanne C; Louis T; Balsat C; Van de Velde M; Kaijalainen S; Kridelka F; Engelholm L; Struman I; Alitalo K; Behrendt N; Paupert J; Noel A
    Nat Commun; 2018 Dec; 9(1):5178. PubMed ID: 30518756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM; Tsai CH; Hung WC
    Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique signal transduction of the VEGF family members VEGF-A and VEGF-E.
    Shibuya M
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1161-6. PubMed ID: 19909239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction.
    Lee AS; Lee JE; Jung YJ; Kim DH; Kang KP; Lee S; Park SK; Lee SY; Kang MJ; Moon WS; Kim HJ; Jeong YB; Sung MJ; Kim W
    Kidney Int; 2013 Jan; 83(1):50-62. PubMed ID: 22932121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
    Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
    Xiong Y; Liu Z; Zhao X; Ruan S; Zhang X; Wang S; Huang T
    Biomed Pharmacother; 2018 Oct; 106():1-7. PubMed ID: 29940537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.
    Jeon BH; Jang C; Han J; Kataru RP; Piao L; Jung K; Cha HJ; Schwendener RA; Jang KY; Kim KS; Alitalo K; Koh GY
    Cancer Res; 2008 Feb; 68(4):1100-9. PubMed ID: 18281485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.